Consistent Response on Challenge and Rechallenge of Liposomal Irinotecan in a Patient with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine plus Nab-Paclitaxel: A Case Report.

Kim, Seong-Ryong; Lee, Hyun Jung; Kim, Dalyong

Kim, Seong-Ryong; Lee, Hyun Jung; Kim, Dalyong.

Afiliación

Kim SR; Department of Surgery, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea.
Lee HJ; Division of Hematology & Medical Oncology, Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea.
Kim D; Division of Hematology & Medical Oncology, Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea.

Case Rep Oncol ; 14(3): 1882-1888, 2021.

Article en En | MEDLINE | ID: mdl-35111024

Palabras clave

Case report; Chemotherapy; Liposomal irinotecan; Metastasis; Neoadjuvant chemotherapy; Pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google